SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-22-107054
Filing Date
2022-10-07
Accepted
2022-10-07 14:12:11
Documents
6
Period of Report
2022-10-07

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2227063d2_6k.htm 6-K 12646
2 EXHIBIT 99.1 tm2227063d2_ex99-1.htm EX-99.1 109228
3 EXHIBIT 99.2 tm2227063d2_ex99-2.htm EX-99.2 4767
4 EXHIBIT 99.3 tm2227063d2_ex99-3.htm EX-99.3 5796
5 EXHIBIT 99.4 tm2227063d2_ex99-4.htm EX-99.4 11973
6 EXHIBIT 99.5 tm2227063d2_ex99-5.htm EX-99.5 57761
  Complete submission text file 0001104659-22-107054.txt   203275
Mailing Address 610 - 700 WEST PENDER STREET VANCOUVER A1 V6C 1G8
Business Address 610 - 700 WEST PENDER STREET VANCOUVER A1 V6C 1G8 604-218-4766
Curaleaf Holdings, Inc. (Filer) CIK: 0001756770 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 333-249081 | Film No.: 221300321
SIC: 2833 Medicinal Chemicals & Botanical Products